SAMSUNG PHARM. Co., LTD. (KRX:001360)
South Korea
· Delayed Price · Currency is KRW 1,490.00
-12.00 (-0.80%)
Last updated: May 9, 2025
SAMSUNG PHARM. Co., LTD. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2018 | FY 2017 | FY 2016 | 2011 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | 2011 - 2015 |
| Operating Revenue | 44,294 | 51,955 | 46,484 | 41,919 | 47,194 | Upgrade
|
| Other Revenue | - | - | - | - | 0 | Upgrade
|
| Revenue | 44,294 | 51,955 | 46,484 | 41,919 | 47,194 | Upgrade
|
| Revenue Growth (YoY) | -14.74% | 11.77% | 10.89% | -11.18% | 11.93% | Upgrade
|
| Cost of Revenue | - | - | 37,903 | 36,851 | 38,425 | Upgrade
|
| Gross Profit | 44,294 | 51,955 | 8,580 | 5,069 | 8,770 | Upgrade
|
| Selling, General & Admin | - | - | 12,228 | 11,708 | 15,001 | Upgrade
|
| Research & Development | - | - | 377.51 | 938.79 | 898.61 | Upgrade
|
| Other Operating Expenses | 29,465 | 33,918 | 755.65 | 261.64 | 475.91 | Upgrade
|
| Operating Expenses | 29,465 | 33,918 | 13,980 | 12,843 | 15,096 | Upgrade
|
| Operating Income | 14,829 | 18,037 | -5,399 | -7,774 | -6,327 | Upgrade
|
| Interest Expense | - | - | -1,357 | -2,590 | -2,456 | Upgrade
|
| Interest & Investment Income | - | - | 1,246 | 692.21 | 323.74 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -9.87 | -26.54 | 45.02 | Upgrade
|
| Other Non Operating Income (Expenses) | -2,117 | 5,638 | 273.82 | -870.64 | -1,665 | Upgrade
|
| EBT Excluding Unusual Items | 12,711 | 23,675 | -5,246 | -10,569 | -10,079 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 3,203 | -117.01 | -3,605 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 27 | 292.49 | 13.04 | Upgrade
|
| Asset Writedown | - | - | - | -577.53 | -3,067 | Upgrade
|
| Other Unusual Items | - | - | - | 5.46 | -609.29 | Upgrade
|
| Pretax Income | 12,711 | 23,675 | -2,016 | -10,966 | -17,348 | Upgrade
|
| Income Tax Expense | - | -1,137 | 59.55 | -3,692 | -129.71 | Upgrade
|
| Earnings From Continuing Operations | 12,711 | 24,812 | -2,076 | -7,274 | -17,218 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | -265.93 | -4,400 | Upgrade
|
| Net Income to Company | 12,711 | 24,812 | -2,076 | -7,540 | -21,618 | Upgrade
|
| Minority Interest in Earnings | - | - | - | -0 | 0 | Upgrade
|
| Net Income | 12,711 | 24,812 | -2,076 | -7,540 | -21,618 | Upgrade
|
| Net Income to Common | 12,711 | 24,812 | -2,076 | -7,540 | -21,618 | Upgrade
|
| Net Income Growth | -48.77% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | - | - | 51 | 40 | 33 | Upgrade
|
| Shares Outstanding (Diluted) | - | - | 51 | 40 | 33 | Upgrade
|
| Shares Change (YoY) | - | - | 28.44% | 21.80% | 28.46% | Upgrade
|
| EPS (Basic) | - | - | -40.51 | -189.00 | -660.00 | Upgrade
|
| EPS (Diluted) | - | - | -40.51 | -189.00 | -660.00 | Upgrade
|
| Free Cash Flow | - | - | -9,134 | -956.01 | -43,177 | Upgrade
|
| Free Cash Flow Per Share | - | - | -178.27 | -23.96 | -1318.23 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 18.46% | 12.09% | 18.58% | Upgrade
|
| Operating Margin | 33.48% | 34.72% | -11.62% | -18.55% | -13.41% | Upgrade
|
| Profit Margin | 28.70% | 47.76% | -4.46% | -17.99% | -45.80% | Upgrade
|
| Free Cash Flow Margin | - | - | -19.65% | -2.28% | -91.49% | Upgrade
|
| EBITDA | - | - | -1,635 | -3,859 | -2,060 | Upgrade
|
| EBITDA Margin | - | - | -3.52% | -9.21% | -4.37% | Upgrade
|
| D&A For EBITDA | - | - | 3,764 | 3,915 | 4,267 | Upgrade
|
| EBIT | 14,829 | 18,037 | -5,399 | -7,774 | -6,327 | Upgrade
|
| EBIT Margin | 33.48% | 34.72% | -11.62% | -18.55% | -13.41% | Upgrade
|
| Advertising Expenses | - | - | 921.87 | 150.94 | 975.62 | Upgrade
|
Updated Nov 14, 2019. Source: S&P Global Market Intelligence. Standard template. Financial Sources.